Quantitative Targeted Absolute Proteomic Analysis of Transporters, Receptors and Junction Proteins for Validation of Human Cerebral Microvascular Endothelial Cell Line hCMEC/D3 as a Human Blood–Brain Barrier Model
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Human cerebral microvascular endothelial cell line hCMEC/D3 is an established model of the human blood-brain barrier (BBB). The purpose of the present study was to determine, by means of quantitative targeted absolute proteomics, the protein expression levels in hCMEC/D3 cells of multiple transporters, receptors and junction proteins for comparison with our previously reported findings in isolated human brain microvessels. Among 91 target molecules, 12 transporters, 2 receptors, 1 junction protein and 1 membrane marker were present at quantifiable levels in plasma membrane fraction of hCMEC/D3 cells. ABCA2, MDR1, MRP4, BCRP, GLUT1, 4F2hc, MCT1, ENT1, transferrin and insulin receptors and claudin-5 were detected in both hCMEC/D3 cells and human brain microvessels. After normalization based on Na(+)/K(+) ATPase expression, the differences in protein expression levels between hCMEC/D3 cells and human brain microvessels were within 4-fold for these proteins, with the exceptions of ENT1, transferrin receptor and claudin-5. ABCA8, LAT1, LRP1 and γ-GTP were below the limit of quantification in the cells, but were found in human brain microvessels. ABCA3, ABCA6, MRP1 and ATA1 were found only in hCMEC/D3 cells. Furthermore, compared with human umbilical vein endothelial cells (HUVECs) as reference nonbrain endothelial cells, MDR1 was found only in hCMEC/D3 cells, and GLUT1 expression was 15-fold higher in hCMEC/D3 cells than in HUVECs. In conclusion, this is the first study to examine the suitability and limitations of the hCMEC/D3 cell line as a BBB functional model in terms of quantitative expression levels of transporters, receptors and tight junction proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Shawahna, R., Uchida, Y., Declèves, X., Ohtsuki, S., Yousif, S., Dauchy, S., Jacob, A., Chassoux, F., Daumas-Duport, C., Couraud, P.-O., et al. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200129p · Cited by 372
Self-citationThe 4F2hc/LAT1 complex transports l-DOPA across the blood–brain barrier
Kageyama, T., Nakamura, M., Matsuo, A., Yamasaki, Y., Takakura, Y., Hashida, M., Kanai, Y., Naito, M., Tsuruo, T., Minato, N., et al. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02758-x · Cited by 298
Impact of Oatp1c1 deficiency on thyroid hormone metabolism and action in the mouse brain
Mayerl, S., Visser, T. J., Darras, V. M., Horn, S., & Heuer, H. (2012) · Endocrinology · doi:10.1210/en.2011-1633 · Cited by 138
Tamaki, C., Ohtsuki, S., & Terasaki, T. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.036913 · Cited by 111
Self-citation
Research works printed but not linked: 35
- Ohtsuki S., 2007, Pharm. Res., 24, 1745, 10.1007/s11095-007-9374-5 · DOI · Paper page
- Kusuhara H., 2005, NeuroRx, 2, 73, 10.1602/neurorx.2.1.73 · DOI · Paper page
- Ohtsuki S., 2007, Pharm. Res., 24, 688, 10.1007/s11095-006-9188-x · DOI
- Leino R. L., 1999, Brain Res. Dev. Brain Res., 113, 47, 10.1016/S0165-3806(98)00188-6 · DOI · Paper page
- Ohtsuki S., 2006, Biol. Pharm. Bull., 29, 1587, 10.1248/bpb.29.1587 · DOI
- Ohtsuki S., 2010, Biol. Pharm. Bull., 33, 1250, 10.1248/bpb.33.1250 · DOI
- Che C., 2010, J. Med. Chem., 53, 2814, 10.1021/jm9016637 · DOI · Paper page
- Pardridge W. M., 2005, NeuroRx, 2, 129, 10.1602/neurorx.2.1.129 · DOI
- Ito S., 2011, J. Cereb. Blood Flow Metab., 31, 457, 10.1038/jcbfm.2010.108 · DOI
- Warren M. S., 2009, Pharmacol. Res., 59, 404, 10.1016/j.phrs.2009.02.007 · DOI · Paper page
- Ohtsuki S., 2011, J. Pharm. Sci., 100, 3547, 10.1002/jps.22612 · DOI
- Uchida Y., 2011, J. Neurochem., 117, 333, 10.1111/j.1471-4159.2011.07208.x · DOI · Paper page
- Carl S. M., 2010, Mol. Pharmaceutics, 7, 1057, 10.1021/mp900178j · DOI · Paper page
- Dauchy S., 2009, Biochem. Pharmacol., 77, 897, 10.1016/j.bcp.2008.11.001 · DOI · Paper page
- Poller B., 2008, J. Neurochem., 107, 1358, 10.1111/j.1471-4159.2008.05730.x · DOI · Paper page
- Weksler B. B., 2005, FASEB J., 19, 1872, 10.1096/fj.04-3458fje · DOI · Paper page
- Fasler-Kan E., 2010, Brain Res., 1354, 15, 10.1016/j.brainres.2010.07.077 · DOI
- Hurst L. A., 2009, J. Neuroimmunol., 210, 108, 10.1016/j.jneuroim.2009.02.008 · DOI
- Joice S. L., 2009, Brain Res., 1298, 13, 10.1016/j.brainres.2009.08.076 · DOI
- Lim J. C., 2008, J. Neurochem., 106, 1855, 10.1111/j.1471-4159.2008.05537.x · DOI · Paper page
- Luissint A. C., 2012, J. Cereb. Blood Flow Metab., 32, 860, 10.1038/jcbfm.2011.202 · DOI · Paper page
- Ohtsuki S., 2012, Drug Metab. Dispos., 40, 83, 10.1124/dmd.111.042259 · DOI · Paper page
- Kamiie J., 2008, Pharm. Res., 25, 1469, 10.1007/s11095-008-9532-4 · DOI · Paper page
- Ito S., 2006, Neurosci. Res., 56, 246, 10.1016/j.neures.2006.07.006 · DOI · Paper page
- Cornford E. M., 2005, NeuroRx, 2, 27, 10.1602/neurorx.2.1.27 · DOI
- Seetharaman S., 1998, J. Neurochem., 70, 1151, 10.1046/j.1471-4159.1998.70031151.x · DOI · Paper page
- Leong H. X., 2006, Nutr. Metab., 3, 37, 10.1186/1743-7075-3-37 · DOI
- Liu X. M., 2004, FASEB J., 18, 768, 10.1096/fj.03-0886fje · DOI · Paper page
- Boado R. J., 2003, J. Neurochem., 85, 1037, 10.1046/j.1471-4159.2003.01757.x · DOI
- Piehler A. P., 2012, Front. Psychiatry, 3, 17, 10.3389/fpsyt.2012.00017 · DOI · Paper page
- Yoshida I., 2004, Biochem. Biophys. Res. Commun., 323, 547, 10.1016/j.bbrc.2004.08.133 · DOI
- Kim W. S., 2006, NeuroReport, 17, 891, 10.1097/01.wnr.0000221833.41340.cd · DOI · Paper page
- Ito K., 2011, J. Pharm. Sci., 100, 3939, 10.1002/jps.22487 · DOI · Paper page
- Ciccimaro E., 2009, Anal. Chem., 81, 3304, 10.1021/ac900204f · DOI
- Domanski D., 2010, Anal. Chem., 82, 5610, 10.1021/ac1005553 · DOI · Paper page
Cited by
Helms, H. C., Abbott, N. J., Burek, M., Cecchelli, R., Couraud, P.-O., Deli, M. A., Förster, C., Galla, H. J., Romero, I. A., Shusta, E. V., et al. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16630991 · Cited by 843
Self-citationThe hCMEC/D3 cell line as a model of the human blood brain barrier
Weksler, B., Romero, I. A., & Couraud, P.-O. (2013) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-10-16 · Cited by 753
“In agreement with these data, a high level of SLC16A1 expression at the protein level was detected by quantitative proteomic analysis of hCMEC/D3 cell extracts [19].”
InfluentialSelf-citationGlucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery
Patching, S. G. (2017) · Molecular Neurobiology · doi:10.1007/s12035-015-9672-6 · Cited by 361
A Historical Review of Brain Drug Delivery
Pardridge, W. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061283 · Cited by 219
Hladky, S. B., & Barrand, M. A. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0113-6 · Cited by 206
Stem Cell-Based Human Blood–Brain Barrier Models for Drug Discovery and Delivery
Aday, S., Cecchelli, R., Hallier-Vanuxeem, D., Dehouck, M. P., & Ferreira, L. (2016) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.01.001 · Cited by 169
Saunders, N. R., Habgood, M. D., Møllgård, K., & Dziegielewska, K. M. (2016) · F1000Research · doi:10.12688/f1000research.7378.1 · Cited by 143
Prasad, S., Sajja, R. K., Park, J. H., Naik, P., Kaisar, M. A., & Cucullo, L. (2015) · Fluids and Barriers of the CNS · doi:10.1186/s12987-015-0014-x · Cited by 77
Deng, L., Spencer, B. L., Holmes, J. A., Mu, R., Rego, S., Weston, T. A., Hu, Y., Sanches, G. F., Yoon, S., Park, N., et al. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1007848 · Cited by 74
Lamartinière, Y., Boucau, M.-C., Dehouck, L., Krohn, M., Pahnke, J., Candela, P., Gosselet, F., & Fenart, L. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170883 · Cited by 50
Co-Culture Models: Key Players in In Vitro Neurotoxicity, Neurodegeneration and BBB Modeling Studies
Monteiro, A. R., Barbosa, D. J., Remião, F., & Silva, R. (2024) · Biomedicines · doi:10.3390/biomedicines12030626 · Cited by 27
Metadata
- Authors
- Ohtsuki, S., Ikeda, C., Uchida, Y., Sakamoto, Y., Miller, F., Glacial, F., Decleves, X., Scherrmann, J.-M., Couraud, P.-O., Kubo, Y., Tachikawa, M., & Terasaki, T.
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-12-11
- Volume
- 10
- Issue
- 1
- Pages
- 289-296
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- OpenAlex
- W2059636317
- Cited by
- 230
- References
- 6
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.